| Literature DB >> 34505750 |
Mirac Musaoğlu1, Muhammed Yuksel1,2, Ozlem Mizikoglu1, Cigdem Arikan1,2.
Abstract
BACKGROUND: The delivery of healthcare services by telemedicine decreases costs of traveling for patients, is less time-consuming, and most importantly permits the connection between highly skilled specialists and patients. However, whether the use of telemedicine (text messaging) for LT patients was affected by the COVID-19 pandemic is unknown.Entities:
Keywords: SARS-CoV-2; children; immunosuppression; solid-organ transplantation; telehealth; telemedicine
Mesh:
Year: 2021 PMID: 34505750 PMCID: PMC8646366 DOI: 10.1111/petr.14138
Source DB: PubMed Journal: Pediatr Transplant ISSN: 1397-3142
Questionnaire for satisfaction
|
1 Very un satisfying |
2 Un satisfying |
3 Moderately satisfying |
4 Satisfying |
5 Very satisfying | |
|---|---|---|---|---|---|
| My physician was able to address all my clinical needs to my satisfaction | |||||
| I was satisfied with my telehealth visit |
Demographic data
| Parameters | |
|---|---|
| Number of patients | 57 |
| Gender (female/male) | 24/33 |
| Age median (IQR) | 47 (9–91) |
| Primary liver disease: | |
| Autoimmune | 1 |
| Cholestatic | 22 |
| Metabolic | 14 |
| Cryptogenic | 13 |
| Malignancy | 2 |
| Hydrodynamic problems (Budd Chiari) | 1 |
| Acute liver failure | 4 |
| PELD/MELD score (IQR) | 16.50 (11.75–20.00) |
Abbreviations: MELD, model for end‐stage liver disease; PELD, pediatric end‐stage liver disease.
Number, proportion and reason of messaging
| Parameters | (%) pre‐COVID−19 | (%) post‐COVID−19 |
|
|---|---|---|---|
| Total messages | 328 | 395 | na |
| Fever | 12 (3.66%) | 15 (3.80) | 1 |
| Drug use | 74 (22.56%) | 83 (21.01%) | .65 |
| Prescription | 53 (16.16%) | 60 (15.19%) | .75 |
| Follow‐up discussion | 83 (25.30%) | 132 (33.42%) | .02 |
| Liver biopsy related | 13 (3.96%) | 20 (5.06%) | .59 |
| Vaccination | 6 (1.83%) | 13 (3.29%) | .25 |
| Surgical site related | 9 (2.74%) | 4 (1.01%) | .09 |
| Bleeding | 6 (1.83%) | 2 (0.51%) | .15 |
| Abdominal pain | 6 (1.83%) | 5 (1.27%) | .55 |
| Nausea/vomiting | 6 (1.83%) | 9 (2.28%) | .79 |
| Cough | 3 (0.91%) | 3 (0.76%) | 1 |
| Diarrhea | 3 (0.91%) | 5 (1.27%) | .73 |
| Sore throat | 4 (1.22%) | 1 (0.25%) | .18 |
| Rashes | 3 (0.91%) | 7 (1.77%) | .36 |
| Rhinorrhea | 5 (1.52%) | 1 (0.25%) | .09 |
| Swelling of the eye | 1 (0.30%) | 3 (0.76%) | .63 |
| Jaundice | 2 (0.61%) | 1 (0.25%) | 1 |
|
Others (MRI scan, referrals, being irritated, itching, loss of appetite, failure to thrive, fatigue, complementary food, acne, anuria, bone pain, headache, confusion, knee pain, earache, disease report, exercise, oral aphthae, sneezing, unusual stool, constipation, and diet) | 39 (9.45%) | 31 (4.81%) | .07 |
Abbreviation: MRI: magnetic resonance imaging.